On May 20, Lake Street will host a virtual meeting focused on TLSI. This event offers investors an opportunity to gain insights into the company's current performance and future prospects. The meeting aims to provide detailed analysis that could guide investors in making informed decisions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for TriSalus Life Sciences Inc (TLSI, Financial) is $11.44 with a high estimate of $16.00 and a low estimate of $10.00. The average target implies an upside of 116.01% from the current price of $5.30. More detailed estimate data can be found on the TriSalus Life Sciences Inc (TLSI) Forecast page.
Based on the consensus recommendation from 8 brokerage firms, TriSalus Life Sciences Inc's (TLSI, Financial) average brokerage recommendation is currently 1.9, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
